25 March 2021: Ncondezi Energy Limited (“Ncondezi” or the “Company”) (AIM: NCCL) is pleased to provide an update on the integrated Ncondezi 300MW coal fired power project and coal mine in Tete, Mozambique (the “Project”).
This summary builds on our recent announcements of 27 October and 9 November as work is ongoing across our project portfolio.
Further to the Company’s announcement on 16 April 2020, N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an update on the progress of its Covid-19 proof of concept work for Nuvec®.
Armadale Capital plc (LON: ACP), the AIM quoted investment group focused on natural resource projects in Africa, is pleased to provide an update on the Mahenge Liandu graphite project (‘Mahenge’ or ‘the Project’) in south-east Tanzania as it progresses towards commercialisation in line with the group’s transformation from explorer to emerging producer.
Live Company Group plc (AIM: LVCG) announces that, further to the announcement of 5 October 2018, and the update provided in the Company’s Interim Results
11 October 2019: Ncondezi Energy Limited (“Ncondezi” or the “Company”) (AIM: NCCL) has uploaded an Investor Update Presentation on the
InfraStrata plc (AIM: INFA), the UK quoted company focused on boosting national energy resilience with strategic infrastructure projects, is pleased to provide an update on the workstreams completed at the Islandmagee gas storage project (“Islandmagee Project” or “the Project”) in Northern Ireland.
Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, has been selected by a new Tier 1 supplier to deliver its FOVIO driver monitoring platform into a new generation architecture addressing additional car models for an existing European OEM customer.
Union Jack Oil plc (AIM: UJO), a UK focused onshore hydrocarbon production, development and exploration company is pleased to announce an update in respect of the West Newton A-2 conventional appraisal well, located within PEDL183 and operated by Rathlin Energy (UK) Limited.
Evgen Pharma (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that the last study visit for the last patient entered in the double-blind, placebo-controlled SAS Phase II clinical trial has taken place.